The Incidence and Predictors of Thromboembolic Events in
Patients with Lung Cancer

J 2014

The Incidence and Predictors of Thromboembolic Events in Patients with Lung Cancer

KADLEC, Bohdan, Jana SKŘIČKOVÁ, Zdeněk MERTA, Ladislav DUŠEK, Jiří JARKOVSKÝ et. al.

Basic information

Original name

The Incidence and Predictors of Thromboembolic Events in Patients with Lung Cancer

Authors

KADLEC, Bohdan (203 Czech Republic, belonging to the institution), Jana SKŘIČKOVÁ (203 Czech Republic, guarantor, belonging to the institution), Zdeněk MERTA (203 Czech Republic, belonging to the institution), Ladislav DUŠEK (203 Czech Republic, belonging to the institution) and Jiří JARKOVSKÝ (203 Czech Republic, belonging to the institution)

Edition

The Scientific World Journal, New York, Hindawi Publishing Corporation, 2014, 1537-744X

Other information

Language

English

Type of outcome

Článek v odborném periodiku

Field of Study

30200 3.2 Clinical medicine

Country of publisher

United States of America

Confidentiality degree

není předmětem státního či obchodního tajemství

Impact factor

Impact factor: 1.219 in 2013

RIV identification code

RIV/00216224:14110/14:00075563

Organization unit

Faculty of Medicine

DOI

http://dx.doi.org/10.1155/2014/125706

UT WoS

000330658700001

Keywords in English

D-DIMER LEVELS; VENOUS THROMBOEMBOLISM; TISSUE FACTOR; RISK-FACTORS; PROGNOSTIC-SIGNIFICANCE; TROUSSEAUS-SYNDROME; SQUAMOUS-CELL; THROMBOSIS; ADENOCARCINOMA; CHEMOTHERAPY

Abstract

V originále

Patients with lung cancer experience elevated risk of venous thromboembolism. Cancer patients with thrombosis have a shorter life expectancy and the occurrence of VTE worsens the quality of life and may delay, interrupt, or completely halt the cancer therapy. In a large cohort of lung cancer patients we monitored the incidence of venous thromboembolism and we identified groups of patients with the highest risk of venous thromboembolism suitable for antithrombotic prophylaxis, which could favourably affect their morbidity and mortality.

Citovat

KADLEC, Bohdan, Jana SKŘIČKOVÁ, Zdeněk MERTA, Ladislav DUŠEK and Jiří JARKOVSKÝ. The Incidence and Predictors of Thromboembolic Events in Patients with Lung Cancer. The Scientific World Journal. New York: Hindawi Publishing Corporation, 2014, vol. 2014, "125706", p. 1-9. ISSN 1537-744X. Available from: https://dx.doi.org/10.1155/2014/125706.

@article{1183835,
   author = {Kadlec, Bohdan and Skřičková, Jana and Merta, Zdeněk and Dušek, Ladislav and Jarkovský, Jiří},
   article_location = {New York},
   article_number = {"125706"},
   doi = {http://dx.doi.org/10.1155/2014/125706},
   keywords = {D-DIMER LEVELS; VENOUS THROMBOEMBOLISM; TISSUE FACTOR; RISK-FACTORS; PROGNOSTIC-SIGNIFICANCE; TROUSSEAUS-SYNDROME; SQUAMOUS-CELL; THROMBOSIS; ADENOCARCINOMA; CHEMOTHERAPY},
   language = {eng},
   issn = {1537-744X},
   journal = {The Scientific World Journal},
   title = {The Incidence and Predictors of Thromboembolic Events in Patients with Lung Cancer},
   volume = {2014},
   year = {2014}
}

TY  - JOUR
ID  - 1183835
AU  - Kadlec, Bohdan - Skřičková, Jana - Merta, Zdeněk - Dušek, Ladislav - Jarkovský, Jiří
PY  - 2014
TI  - The Incidence and Predictors of Thromboembolic Events in Patients with Lung Cancer
JF  - The Scientific World Journal
VL  - 2014
IS  - "125706"
SP  - 1-9
EP  - 1-9
PB  - Hindawi Publishing Corporation
SN  - 1537744X
KW  - D-DIMER LEVELS
KW  - VENOUS THROMBOEMBOLISM
KW  - TISSUE FACTOR
KW  - RISK-FACTORS
KW  - PROGNOSTIC-SIGNIFICANCE
KW  - TROUSSEAUS-SYNDROME
KW  - SQUAMOUS-CELL
KW  - THROMBOSIS
KW  - ADENOCARCINOMA
KW  - CHEMOTHERAPY
N2  - Patients with lung cancer experience elevated risk of venous thromboembolism. Cancer patients with thrombosis have a shorter life expectancy and the occurrence of VTE worsens the quality of life and may delay, interrupt, or completely halt the cancer therapy. In a large cohort of lung cancer patients we monitored the incidence of venous thromboembolism and we identified groups of patients with the highest risk of venous thromboembolism suitable for antithrombotic prophylaxis, which could favourably affect their morbidity and mortality.
ER  -

KADLEC, Bohdan, Jana SKŘIČKOVÁ, Zdeněk MERTA, Ladislav DUŠEK and Jiří JARKOVSKÝ. The Incidence and Predictors of Thromboembolic Events in Patients with Lung Cancer. \textit{The Scientific World Journal}. New York: Hindawi Publishing Corporation, 2014, vol.~2014, ''125706'', p.~1-9. ISSN~1537-744X. Available from: https://dx.doi.org/10.1155/2014/125706.

Detailed Information on Publication Record